| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.69 | 0.006 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.2 | 0.2 |